These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26871779)

  • 1. Putaminal Diffusivity Correlates With Disease Progression in Parkinson's Disease: Prospective 6-Year Study.
    Chan LL; Ng KM; Yeoh CS; Rumpel H; Li HH; Tan EK
    Medicine (Baltimore); 2016 Feb; 95(6):e2594. PubMed ID: 26871779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case control study of diffusion tensor imaging in Parkinson's disease.
    Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
    Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
    Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial deep gray nuclear DTI changes in Parkinson's disease over twelve years.
    Shih YC; Ooi LQR; Li HH; Allen JC; Hartono S; Welton T; Tan EK; Chan LL
    Front Aging Neurosci; 2023; 15():1169254. PubMed ID: 37409008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
    Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
    Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.
    Surova Y; Nilsson M; Lampinen B; Lätt J; Hall S; Widner H; van Westen D; Hansson O
    Neuroradiology; 2018 Mar; 60(3):247-254. PubMed ID: 29368035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging.
    Zhan W; Kang GA; Glass GA; Zhang Y; Shirley C; Millin R; Possin KL; Nezamzadeh M; Weiner MW; Marks WJ; Schuff N
    Mov Disord; 2012 Jan; 27(1):90-7. PubMed ID: 21850668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging.
    Nair SR; Tan LK; Mohd Ramli N; Lim SY; Rahmat K; Mohd Nor H
    Eur Radiol; 2013 Jun; 23(6):1459-66. PubMed ID: 23300042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
    PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.
    Loane C; Politis M; Kefalopoulou Z; Valle-Guzman N; Paul G; Widner H; Foltynie T; Barker RA; Piccini P
    Mov Disord; 2016 Jul; 31(7):1020-6. PubMed ID: 27104232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.
    Minett T; Su L; Mak E; Williams G; Firbank M; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn D; O'Brien JT
    J Neurol; 2018 Jul; 265(7):1528-1539. PubMed ID: 29696499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
    Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
    Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DTI correlates of distinct cognitive impairments in Parkinson's disease.
    Zheng Z; Shemmassian S; Wijekoon C; Kim W; Bookheimer SY; Pouratian N
    Hum Brain Mapp; 2014 Apr; 35(4):1325-33. PubMed ID: 23417856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson's disease.
    Shang S; Li D; Tian Y; Li R; Zhao H; Zheng L; Zhang Y; Chen YC; Yin X
    Commun Biol; 2021 Oct; 4(1):1162. PubMed ID: 34621005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson's Disease: Challenging Results.
    Lenfeldt N; Eriksson J; Åström B; Forsgren L; Mo SJ
    J Parkinsons Dis; 2017; 7(1):129-142. PubMed ID: 28106567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.